From EST to IHC: human antibody pipeline for target research
- 1 February 2003
- journal article
- Published by Elsevier in Journal of Immunological Methods
- Vol. 275 (1-2), 203-212
- https://doi.org/10.1016/s0022-1759(03)00011-5
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- High-throughput generation and engineering of recombinant human antibodiesJournal of Immunological Methods, 2001
- Fully synthetic human combinatorial antibody libraries (HuCAL) based on modular consensus frameworks and CDRs randomized with trinucleotides 1 1Edited by I. A. WilsonJournal of Molecular Biology, 2000
- Selectively infective phage (SIP) technology: scope and limitationsJournal of Immunological Methods, 1999
- High-level expression of soluble heterologous proteins in the cytoplasm of Escherichia coli by fusion to the bacteriophage Lambda head protein DGene, 1998
- Strategies for optimizing heterologous protein expression in Escherichia coliTrends in Biotechnology, 1998
- Selectively-infective phage (SIP): a mechanistic dissection of a novel in vivo selection for protein-ligand interactionsJournal of Molecular Biology, 1997
- A conserved infection pathway for filamentous bacteriophages is suggested by the structure of the membrane penetration domain of the minor coat protein g3p from phage fdStructure, 1997
- Co‐selection of cognate antibody‐antigen pairs by selectively‐infective phagesFEBS Letters, 1995
- Characterization of the linker peptide of the single‐chain Fv fragment of an antibody by NMR spectroscopyFEBS Letters, 1993
- Calculation of protein extinction coefficients from amino acid sequence dataAnalytical Biochemistry, 1989